Check out our resource library!
PUBLICATIONS AND POSTERS
Telix Pharmaceuticals Limited is proud to share our resource library of publications, posters and presentations about our investigational pipeline candidates.
May 2020 – American Society of Clinical Oncology (ASCO) | Central Nervous System Tumors
IPAX-1: PHASE 1/2 STUDY OF 4-L-[131I] IODO-PHENYLALANINE (131I-IPA) COMBINED WITH EXTERNAL RADIATION THERAPY (XRT) AS TREATMENT FOR PATIENTS WITH GLIOBLASTOMA MULTIFORME
Josef Pichler1, Rosalind Wilson2
1Kepler University Hospital, Linz, Austria; 2Telix Pharmaceuticals, Melbourne, Australia.
To download PDF please click here.